Charles Schwab Investment Management Inc Acrivon Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 143,958 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,958
Previous 77,382
86.04%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ACRV
# of Institutions
53Shares Held
23.7MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.12MShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0949KShares$00.0% of portfolio